RAINDROP NEAR VISION INLAY
Report
- Report Number
- 3005956347-2017-00129
- Event Type
- Injury
- Date Received
- October 24, 2017
- Date of Event
- September 8, 2017
- Report Date
- October 24, 2017
- Manufacturer
- REVISION OPTICS, INC.
- Product Code
- LQE
- UDI-DI
- 10850394006013
- PMA / PMN Number
- P150034
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TX, US
- Reporter Occupation
- MEDICAL TECHNOLOGIST
Narratives
THE EXPLANTED INLAY WAS RETURNED TO THE MANUFACTURER AND SUBJECTED TO VISUAL MICROSCOPIC INSPECTION AND DIMENSIONAL ANALYSIS. THE EDGE THICKNESS AND DIAMETER WERE MEASURED AND FOUND TO BE WITHIN SPECIFICATIONS. THE INLAY HAD A VERY SMALL CUT NEAR THE EDGE AND SOME PARTICLES WERE OBSERVED ON THE SURFACE, BUT THESE FINDINGS ARE CONSISTENT WITH FINDINGS FOR CORNEAL INLAYS THAT HAVE BEEN EXPLANTED SINCE SURGICAL INSTRUMENTS ARE REQUIRED TO REMOVE THE DEVICE FROM THE EYE AND PLACE IT IN A HYDRATED STORAGE CONTAINER FOR TRANSPORT. THE DEVICE HISTORY RECORD REVIEW OF THE MANUFACTURING LOT WAS PERFORMED AND THERE WERE NO DISCREPANCIES OR UNUSUAL FINDINGS RELATED TO THE REPORTED ISSUE. INLAY SHIFTS IN POSITON AND DECREASED VISION ARE LISTED IN THE DEVICE LABELING AS KNOWN POTENTIAL RISKS. COMPLAINT REFERENCE #: (B)(4).
THE PATIENT UNDERWENT UNEVENTFUL IMPLANTATION OF THE RAINDROP CORNEAL INLAY IN THE LEFT EYE ON (B)(6) 2017. THE INLAY DECENTERED 3 MM INFERIORLY AND RESULTED IN A DECREASE IN BEST CORRECTED DISTANCE VISUAL ACUITY (BCDVA) FROM 20/20 PREOPERATIVELY TO 20/70-1. THE INLAY WAS EXPLANTED ON (B)(6) 2017. AT LAST EXAMINATION ONE MONTH POST EXPLANT BCDVA IMPROVED TO 20/20-1 AND THE CORNEA WAS HEALING IDEALLY. THE SURGEON ATTRIBUTED THE INLAY DECENTRATION TO A STEROID-INDUCED IOP SPIKE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 753115 | RAINDROP NEAR VISION INLAY | CORNEAL INLAY | LQE | REVISION OPTICS, INC. | 610-0001 | 003132 | 10850394006013 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 51 YR | Required Intervention |